Creating an FDA approved drug requires an investment in clinical research; additionally, innovation comes with staying up-to-date on data from the field.
We understand this framework well and are moving along quickly toward completion of controlled clinical studies, as well as publication of our learnings from these studies.
We are committed to sharing our learnings from our research with the field; as part of this commitment, we will post peer-reviewed publications pertaining to our microbiome research and clinical evaluation of formulations in our MRT™ drug platform periodically to this website.
We will also include relevant presentations made to scientific audiences and white papers pertaining to our therapies, as well as thought-leadership pieces in support of the growth of the microbiome field.